AstraZeneca begins US final phase trial of Kovid-19 vaccine

AstraZeneca plc has begun large-scale human trials of its coronavirus vaccine in the US, the company said in a statement, with plans to recruit more than 30,000 adults to test the shot.

The AstraZeneca shot, invented by researchers at the University of Oxford, is the furthest of many Kovid-19 vaccines in development. In addition to the US trial, a final phase of inoculation is underway in the UK and preliminary results are expected as soon as next month. Other companies applying Kovid-19 vaccines in Phase 3 trials include Modern Inc. and Pfizer Inc.


Leave a Reply

Your email address will not be published.